Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Methotrexate
100%
Two-dose
100%
Medical Center
100%
Retrospective Cohort Study
100%
Ectopic Pregnancy
100%
Treatment Efficacy
71%
One Dose
57%
Laparoscopy
28%
Adnexal Mass
28%
95% Confidence Interval
28%
Body Mass Index
14%
Odds Ratio
14%
Risk Factors
14%
No Significant Difference
14%
Treatment Response
14%
Cox Proportional Hazards Model
14%
Treatment Group
14%
Treatment Duration
14%
Medical Management
14%
Median Time
14%
Success Rate
14%
Adjusted Model
14%
Multivariable Logistic Regression
14%
Intramuscular Injection
14%
Prior Infection
14%
Inpatient Treatment
14%
Beta Human Chorionic Gonadotropin (β-HCG)
14%
Serum β-human Chorionic Gonadotropin
14%
Statistically Significant Difference
14%
Time to Resolution
14%
Optimal Dosing Regimen
14%
Nursing and Health Professions
Methotrexate
100%
Cohort Analysis
100%
Ectopic Pregnancy
100%
Confidence Interval
28%
Laparoscopic Surgery
28%
Chorionic Gonadotropin Beta Subunit
28%
Proportional Hazards Model
14%
Infection
14%
Logistic Regression Analysis
14%
Body Mass
14%
Disease Management
14%
Odds Ratio
14%
Treatment Response
14%
Treatment Duration
14%
Intramuscular Drug Administration
14%
Treatment Group
14%
Efficacy
14%
Medicine and Dentistry
Methotrexate
100%
Retrospective Cohort Study
100%
Ectopic Pregnancy
100%
Adnexal Mass
28%
Laparoscopic Surgery
28%
Chorionic Gonadotropin Beta Subunit
28%
Proportional Hazards Model
14%
Infection
14%
Logistic Regression Analysis
14%
Body Mass Index
14%
Retrospective Study
14%
Treatment Response
14%
Treatment Duration
14%
Intramuscular Injection
14%
Treatment Group
14%
Odds Ratio
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Methotrexate
100%
Ectopic Pregnancy
100%
Chorionic Gonadotropin Beta Subunit
28%
Infection
14%
Retrospective Study
14%
Intramuscular Injection
14%
Treatment Group
14%